For example, in a signaling network involving extracellular signal-related kinase (ERK), RhoA and FAK are dysregulated in high-grade non-small cell lung cancer (NSCLC) occurring against a background of Ink4a-Arf deficiency [16]. Here, CDKN2A is linked to non-small cell lung carcinoma.